The Neuro RX Gamma device delivers near infrared light to the brain via the head and the nose, a process known as brain photobiomodulation (PBM).
It is a simple and non-invasive home-based treatment.
This clinical trial is designed to evaluate the efficacy of the Neuro RX Gamma device in moderate to severe Alzheimer’s disease.
The trial will recruit 228 participants across 12 sites in North America. (Toronto, Ottawa, Vancouver, Florida)